Clinical Trials Browser

Interventional × Pathologic Complete Response × toripalimab × Clear all

NCT04006041 2019-12-26

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response